Literature DB >> 21737610

Therapy-, gender- and race-specific microRNA markers, target genes and networks related to glioblastoma recurrence and survival.

K R Delfino1, N V L Serão, B R Southey, S L Rodriguez-Zas.   

Abstract

AIM: To identify and study targets of microRNA biomarkers of glioblastoma survival across events (death and recurrence) and phases (life expectancy or post-diagnostic) using functional and network analyses.
MATERIALS AND METHODS: microRNAs associated with glioblastoma survival within and across race, gender, recurrence, and therapy cohorts were identified using 253 individuals, 534 microRNAs, Cox survival model, cross-validation, discriminant analyses, and cross-study comparison.
RESULTS: All 45 microRNAs revealed as being associated with survival were confirmed in independent cancer studies and 25 in glioblastoma studies. Thirty-nine and six microRNAs (including hsa-miR-222) were associated with one and multiple glioblastoma survival indicators, respectively. Nineteen and 26 microRNAs exhibited cohort-dependent (including hsa-miR-10b with therapy and hsa-miR-486 with race) and independent associations with glioblastoma, respectively.
CONCLUSION: Sensory perception and G protein-coupled receptor processes were enriched among microRNA gene targets also associated with survival and network visualization highlighted their relations. These findings can help to improve prognostic tools and personalized treatments.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21737610      PMCID: PMC3321577     

Source DB:  PubMed          Journal:  Cancer Genomics Proteomics        ISSN: 1109-6535            Impact factor:   4.069


  59 in total

1.  KEGG: kyoto encyclopedia of genes and genomes.

Authors:  M Kanehisa; S Goto
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  MiRNA-196 is upregulated in glioblastoma but not in anaplastic astrocytoma and has prognostic significance.

Authors:  Yanlei Guan; Masahiro Mizoguchi; Koji Yoshimoto; Nobuhiro Hata; Tadahisa Shono; Satoshi O Suzuki; Yukie Araki; Daisuke Kuga; Akira Nakamizo; Toshiyuki Amano; Xinlong Ma; Kenshi Hayashi; Tomio Sasaki
Journal:  Clin Cancer Res       Date:  2010-07-02       Impact factor: 12.531

3.  Extensive modulation of a set of microRNAs in primary glioblastoma.

Authors:  S A Ciafrè; S Galardi; A Mangiola; M Ferracin; C-G Liu; G Sabatino; M Negrini; G Maira; C M Croce; M G Farace
Journal:  Biochem Biophys Res Commun       Date:  2005-09-09       Impact factor: 3.575

4.  Identification of novel Epstein-Barr virus microRNA genes from nasopharyngeal carcinomas.

Authors:  Jia Yun Zhu; Thorsten Pfuhl; Natalie Motsch; Stephanie Barth; John Nicholls; Friedrich Grässer; Gunter Meister
Journal:  J Virol       Date:  2009-01-14       Impact factor: 5.103

5.  Identification and functional characterization of microRNAs involved in the malignant progression of gliomas.

Authors:  Bastian Malzkorn; Marietta Wolter; Franziska Liesenberg; Michael Grzendowski; Kai Stühler; Helmut E Meyer; Guido Reifenberger
Journal:  Brain Pathol       Date:  2009-09-19       Impact factor: 6.508

6.  Micro-RNA-128 (miRNA-128) down-regulation in glioblastoma targets ARP5 (ANGPTL6), Bmi-1 and E2F-3a, key regulators of brain cell proliferation.

Authors:  J G Cui; Y Zhao; P Sethi; Y Y Li; A Mahta; F Culicchia; W J Lukiw
Journal:  J Neurooncol       Date:  2009-11-26       Impact factor: 4.130

Review 7.  Glioma angiogenesis: Towards novel RNA therapeutics.

Authors:  Thomas Würdinger; Bakhos A Tannous
Journal:  Cell Adh Migr       Date:  2009-04-22       Impact factor: 3.405

8.  Genes involved in radiation therapy response in head and neck cancers.

Authors:  Catherine I Dumur; Amy C Ladd; Harry V Wright; Lynne T Penberthy; David S Wilkinson; Celeste N Powers; Carleton T Garrett; Laurence J DiNardo
Journal:  Laryngoscope       Date:  2009-01       Impact factor: 3.325

9.  Combinatorial control of suicide gene expression by tissue-specific promoter and microRNA regulation for cancer therapy.

Authors:  Chunxiao Wu; Jiakai Lin; Michelle Hong; Yukti Choudhury; Poonam Balani; Doreen Leung; Lam H Dang; Ying Zhao; Jieming Zeng; Shu Wang
Journal:  Mol Ther       Date:  2009-10-06       Impact factor: 11.454

10.  Repertoire of microRNAs in epithelial ovarian cancer as determined by next generation sequencing of small RNA cDNA libraries.

Authors:  Stacia K Wyman; Rachael K Parkin; Patrick S Mitchell; Brian R Fritz; Kathy O'Briant; Andrew K Godwin; Nicole Urban; Charles W Drescher; Beatrice S Knudsen; Muneesh Tewari
Journal:  PLoS One       Date:  2009-04-23       Impact factor: 3.240

View more
  26 in total

1.  Post-transcriptional processing of genetic information and its relation to cancer.

Authors:  Lr McNally; U Manne; W E Grizzle
Journal:  Biotech Histochem       Date:  2013-01-04       Impact factor: 1.718

2.  Opioid-Induced Hyperalgesia Is Associated with Dysregulation of Circadian Rhythm and Adaptive Immune Pathways in the Mouse Trigeminal Ganglia and Nucleus Accumbens.

Authors:  Pan Zhang; Laura S Moye; Bruce R Southey; Isaac Dripps; Jonathan V Sweedler; Amynah Pradhan; Sandra L Rodriguez-Zas
Journal:  Mol Neurobiol       Date:  2019-05-25       Impact factor: 5.590

Review 3.  Current progress for the use of miRNAs in glioblastoma treatment.

Authors:  Amanda Tivnan; Kerrie Leanne McDonald
Journal:  Mol Neurobiol       Date:  2013-04-28       Impact factor: 5.590

4.  Prognostic Role of microRNA-21 Expression in Brain Tumors: a Meta-analysis.

Authors:  Xiao-Yan He; Yu-Dong Liao; Xiao-Qing Guo; Robin Wang; Zhen-Yu Xiao; Yan-Gang Wang
Journal:  Mol Neurobiol       Date:  2015-03-20       Impact factor: 5.590

Review 5.  Epigenetic research in cancer epidemiology: trends, opportunities, and challenges.

Authors:  Mukesh Verma; Scott Rogers; Rao L Divi; Sheri D Schully; Stefanie Nelson; L Joseph Su; Sharon A Ross; Susan Pilch; Deborah M Winn; Muin J Khoury
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-12-10       Impact factor: 4.254

6.  MicroRNA‑21 contributes to renal cell carcinoma cell invasiveness and angiogenesis via the PDCD4/c‑Jun (AP‑1) signalling pathway.

Authors:  Bo Fan; Yiying Jin; Hongshuo Zhang; Rui Zhao; Man Sun; Mengfan Sun; Xiaoying Yuan; Wei Wang; Xiaogang Wang; Zhiqi Chen; Wankai Liu; Na Yu; Qun Wang; Tingjiao Liu; Xiancheng Li
Journal:  Int J Oncol       Date:  2019-12-02       Impact factor: 5.650

7.  Disruption of microglia histone acetylation and protein pathways in mice exhibiting inflammation-associated depression-like symptoms.

Authors:  Sandra L Rodriguez-Zas; Cong Wu; Bruce R Southey; Jason C O'Connor; Scott E Nixon; Robmay Garcia; Cynthia Zavala; Marcus Lawson; Robert H McCusker; Elena V Romanova; Jonathan V Sweedler; Keith W Kelley; Robert Dantzer
Journal:  Psychoneuroendocrinology       Date:  2018-06-30       Impact factor: 4.905

Review 8.  Belonging to a network--microRNAs, extracellular vesicles, and the glioblastoma microenvironment.

Authors:  Jakub Godlewski; Anna M Krichevsky; Mark D Johnson; E Antonio Chiocca; Agnieszka Bronisz
Journal:  Neuro Oncol       Date:  2014-10-09       Impact factor: 12.300

Review 9.  Circulating microRNA biomarkers for glioma and predicting response to therapy.

Authors:  Charlotte A Tumilson; Robert W Lea; Jane E Alder; Lisa Shaw
Journal:  Mol Neurobiol       Date:  2014-04-03       Impact factor: 5.590

10.  Identification and characterization of alternative exon usage linked glioblastoma multiforme survival.

Authors:  Ahmed Sadeque; Nicola Vl Serão; Bruce R Southey; Kristin R Delfino; Sandra L Rodriguez-Zas
Journal:  BMC Med Genomics       Date:  2012-12-04       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.